Ultrasound contrast media in the characterization of soft tissue lesions: Ongoing research

MedicaMundi

Volumn 51, Issue 2-3, 2007, Pages

  Averkiou, M ^a   Powers, J ^b  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; PERFLUBUTANE; PERFLUTREN; SHU 508; SONOVUE; TISSUE PLASMINOGEN ACTIVATOR;

BREAST CANCER; CANCER RESEARCH; CANCER STAGING; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTRAST SENSITIVITY; ECHOGRAPHY; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER INJURY; LIVER RESECTION; LYMPH NODE METASTASIS; METASTASIS; MICROBUBBLE; NODULAR HYPERPLASIA; PROSTATE CANCER; RADIODIAGNOSIS; RADIOFREQUENCY ABLATION; REAL TIME ECHOGRAPHY; REVIEW; STROKE; TUMOR VASCULARIZATION;

EID: 58549088311     PISSN: 00257664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Gramiak R, Shah PM. Echocardiography of the Aortic Root. Invest Radiol, 1968. 3: 356-366.
2. Kremkau FW et al. Ultrasonic Detection of Cavitation at Catheter Tips. Am J Roentgenol Radium Ther Nucl Med 1970; 110,1: 177-183.
3. Becher H et al. Improving Color Doppler Echocardiography of the Right Heart Following Intravenous Injection of SHU 454. Z Kardiol 1988. 77,4: 227-232 (Erratum published in Z Kardiol 1988 77,6: 398).
4. Fritzsch T et al. Preliminary Results with a New Liver Specific Ultrasound Contrast Agent. Ultrasound Med Biol 1994. 20: 137.
5. Angeli E et al. Efficacy of SH U 508 A (Levovist) in Color Doppler Ultrasonography of Hepatocellular Carcinoma Vascularization. Radiol Med,Torino 1994. 87,5 Suppl 1: 24-31.
6. Feinstein SB et al. Safety and Efficacy of a New Transpulmonary Ultrasound Contrast Agent: Initial Multicenter Clinical Results. J Am Coll Cardiol, 1990. 16,2: 316-324.
7. Goldberg BB et al. Galactose-Based Intravenous Sonographic Contrast Agent: Experimental Studies. 1993. 12,8: 463-470.
8. Blomley MJ et al. Improved Imaging of Liver Metastases with Stimulated Acoustic Emission in the Late Phase of Enhancement with the US Contrast Agent SH U 508A: Early Experience. Radiology, 1999. 210,2: 409-416.
9. Burns, PN et al. Harmonic Power Mode Doppler Using Microbubble Contrast Agents: An Improved Method for Small Vessel Flow Imaging. Proc IEEE UFFC 1995: 1547-1550.
10. Burns PN et al. Harmonic Imaging Principles and Preliminary Results. Angiology 1996. 47,7: S63-S74.
11. Leen E, Mcardle CS. Ultrasound Contrast Agents in Liver Imaging. Clin Radiol, 1996. 51 Suppl 1: 35-39.
12. Leighton T. The Acoustic Bubble. Academic Press 1997.
13. Villarraga HR et al. Destruction of Contrast Microbubbles during Ultrasound Imaging at Conventional Power Output. J. Am. Soc. Echocardiography 1997; 10,8: 783-791.
14. Walker KW, Pantely GA, Sahn DA. Ultrasound-Mediated Destruction of Contrast Agents. Effect of Ultrasound Intensity, Exposure, and Frequency. 1997. 32,12: 728-734.
15. Berne RM, Levy MN. Cardiovascular Physiology. 2 Ed. 1972, St. Louis: C.V. Mosby Co, 265.
16. Porter T, Xie F. Transient Myocardial Contrast following Initial Exposure to Diagnostic Ultrasound Pressures with Minute Doses of Intravenously Injected Microbubbles: Demonstration and Potential Mechanisms. In: Advances in Echo Imaging using Contrast Enhancement. N. Nanda, R. Schlief, B. Goldberg, Eds. Kluwer Academic Publishers: Dordrecht, the Netherlands 1996.
17. Porter TR et al. Improved Myocardial Contrast with Second Harmonic Transient Ultrasound Response: Imaging in Humans Using Intravenous Perfluorocarbon-Exposed Sonicated Dextrose Albumin. Journal of American College of Cardiology 1996; 27,6: 1497-1501.
18. Heckemann RA et al. Liver Lesions: Intermittent Second-Harmonic Gray-Scale US can increase Conspicuity with Microbubble Contrast Material - Early Experience. Radiology 2000; 216,2: 592-596.
19. Kim TK et al. Improved Imaging of Hepatic Metastases with Delayed Pulse Inversion Harmonic Imaging Using a Contrast Agent SH U 508A: Preliminary Study. Ultrasound Med Biol, 2000. 26,9: 1439-1444.
20. Wilson SR et al. Harmonic Hepatic US with Microbubble Contrast Agent: Initial Experience Showing Improved Characterization of Hemangioma, Hepatocellular Carcinoma, and Metastasis. Radiology 2000; 215,1: 153-161.
21. Hamilton M, Blackstock D. Nonlinear Acoustics, San Diego, CA: Academic Press 1998.
22. Averkiou MA, Roundhill DN, Powers JE. New Imaging Technique Based On the Nonlinear Properties of Tissues. Proceedings of the IEEE Ultrasonics Symposium 1997; 2: 1561-1566.
23. Hirooka Y et al. Recent Advances in US Diagnosis of Pancreatic Cancer. Hepatogastroenterology 2001; 48,40: 916-922.
24. Burns PN, Wilson SR, Simpson WH. Pulse Inversion Imaging of Liver Blood Flow: Improved Method for Characterizing Focal Masses with Microbubble Contrast. Invest Radiol 2000; 35,1: 58-71.
25. Blornley M et al. Improved Detection of Metastatic Liver Lestons Using Puke Inversion Harmonic Imaging with Levovist: a Multicenter Study. Radiology 1999; 213: 491-495.
26. Folkman JK. Tumor Angiogenesis. In Cancer: A Comprehensive Treatise; 3: 355-388. F Becker (ed) Plenum, New York 1975.
27. Folkman J, Beckner K. Angiogenesis Imaging. Acad Radiol 2000; 7,10: 783-785.
28. Bassingthwaighte J. Physiology and Theory of Tracer Washout Techniques for the Estimation of Myocardial Blood Flow: Flow Estimation from Tracer Washout. Prog Cardiovasc Dis 1977; 20: 165-189.
29. Axel L. Cerebral Blood Flow Determination by Rapid-Sequence Computed Tomography: Theoretical Analysis. Radiology 1980; 137,3: 679-686.
30. Weisskoff RM et al. Pitfalls in MR Measurement of Tissue Blood Flow with Intravascular Tracers: Which Mean Transit Time? Magnetic Resonance in Medicine 1993; 29: 553-559.
31. Blomley MJ, Dawson P. Bolus Dynamics: Theoretical and Experimental Aspects. Br J Radiol 1997; 70,832: 351-359.
32. Albrecht T et al: Non-Invasive Diagnosis of Hepatic Cirrhosis by Transit-Time Analysis of an Ultrasound Contrast Agent. Lancet 1999; 353,9164: 1579-1583.
33. Blomley MJ et al. Liver Microbubble Transit Time Compared with Histology and Child-Pugh Score in Diffuse Liver Disease: A Cross Sectional Study. Gut 2003; 52,8: 1188-1193.
34. Voci P et al. Quantitation of Renal Blood Flow by Contrast Ultrasonography: Preliminary Results. Cardiologia 1989; 34,12: 1001-1006.
35. Wei K et al. Quantification of Myocardial Blood Flow with Ultrasound-Induced Destruction of Microbubbles administered as a Constant Venous Infusion. Circulation 1998; 97,5: 473-483.
36. Tiemann K et al. Quantification of Tissue Perfusion by means of Bubble Destruction using Harmonic Power Doppler Imaging. Circulation 1998; 98,17: 1570.
37. Averkiou M, Bruce M, Powers J. Ultrasonic Diagnostic Imaging with Contrast Agents, in US Patent Office. ATL Ultrasound USA 1998.
38. Wilson SR, Burns PN. Guest Editors' Introduction. Ultrasound Q 2006; 22,1: 3.
39. Meloni MF et al. Radiofrequency Ablation of Liver Tumors: The Role of Microbubble Ultrasound Contrast Agents. Ultrasound Q 2006; 22,1: 41-47.
40. Correas JM et al. The Kidney: Imaging with Microbubble Contrast Agents. Ultrasound Q 2006; 22,1: 53-66.
41. Nicolau C, Vilana R, Bru C. The Use of Contrast-Enhanced Ultrasound in the Management of the Cirrhotic Patient and for Detection of HCC. Eur Radiol 2004; 14 Suppl 8: 63-71.
42. Blomley MJ et al. Stimulated Acoustic Emission to Image a Late Liver and Spleen-specific Phase of Levovist in Normal Volunteers and Patients with and Without Liver Disease. Ultrasound Med Biol 1999; 25,9: 1341-52.
43. Kudo M. Early Detection and Characterization of Hepatocellular Carcinoma: Value of Imaging Multistep Human Hepatocarcinogenesis. Intervirology 2006; 49,1-2: 64-69.
44. Kim HJ et al. Assessment of the Therapeutic Response of Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization: Comparison of Contrast-Enhanced Sonography and 3-Phase Computed Tomography. J Ultrasound Med 2006; 25,4: 477-486.
45. Wilson SR, Burns PN. An Algorithm for the Diagnosis of Focal Liver Masses using Microbubble Contrast-Enhanced Pulse-Inversion Sonography. AJR 2006; 186,5: 1401-1412.
46. Quaia E et al. Comparison of Visual And Quantitative Analysis for Characterization of Insonated Liver Tumors after Microbubble Contrast Injection. AJR 2006; 186,6: 1560-1570.
47. Solbiati L et al. Contrast-Enhanced Ultrasound of Liver Diseases. Springer 2003.
48. Quaia E et al. Comparison of Contrast-enhanced Ultrasonography versus Baseline Ultrasound and Contrast-Enhanced Computed Tomography in Metastatic Disease of the Liver: Diagnostic Performance and Confidence. Eur Radiol 2006; 16,7: 1599-1609.
49. Leen, E et al. Potential Value of Contrast-enhanced Intraoperative Ultrasonography during Partial Hepatectomy for Metastases: An Essential Investigation before Resection? Ann Surg 2006; 243,2: 236-240.
50. Dietrich GF et al. Assessment of Metastatic Liver Disease in Patients with Primary Extrahepatic Tumors by Contrast-enhanced Sonography versus CT and MRI. World J Gastroenterol 2006; 12,11: 1699-1705.
51. Kim TK, Jang HJ, Wilson SR. Benign Liver Masses: Imaging with Microbubble Contrast Agents. Ultrasound Q 2006; 22,1: 31-39.
52. Winterer JT et al. Detection and Characterization of Benign Focal Liver Lesions with Multislice CT. Eur Radiol 2006; 16,11: 2427-2443.
53. Trabulsi EJ, Merriam WG, Gomella LG. New Imaging Techniques in Prostate Cancer. Curr Urol Rep 2006; 7,3: 175-180.